来自Flemingia lineata (L.) W.T.的三个新型二甲基. 艾顿及其抗等离子体活性
Ratih Dewi Saputri1, First Ambar Wati1, Amalia Putri Purnamasari1
1Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Surabaya, Surabaya, Indonesia.
Natural product research
|May 8, 2024
概括
来自弗莱明吉亚线条的新型二甲基和黄具有强大的抗菌活性,可以对菌菌的乳酸脱酶 (PfLDH) 产生强烈的抗菌作用. 化合物2和5表现出显著的抑制作用,突出了它们作为抗疟疾药物领先者的潜力.
科学领域:
- 自然产品 化学 化学
- 药用化学 医学化学
- 寄生虫学的寄生虫学
背景情况:
- Flemingia lineata 是一种因其潜在的药用特性而闻名的植物物种.
- 菌乳酸脱酶 (PfLDH) 是抗疟疾疗法的验证药物标.
- 二甲和黄是具有多种生物活性的自然产品类别.
研究的目的:
- 隔离和描述来自弗莱明基亚系的新型二甲基.
- 评估隔离化合物的抗原菌活性,以对抗原菌.
- 从自然资源中识别潜在的抗疟疾药物候选者.
主要方法:
- 弗莱明吉亚线状叶的植物化学研究.
- 使用NMR光谱和高分辨率ESIMS. 单独化合物的结构阐明.
- 在体外抗等离子体活性测定对抗Plasmodium falciparum乳酸脱酶 (PfLDH).
主要成果:
- 分离出了三种新的二甲基,一种叫做flemilineatins C-E (1-3),以及两种已知的flavanones (4-5).
- 通过光谱学数据证实了二甲基1-3的结构.
- 化合物2和5表现出强烈的抗质活性,IC50值分别为0.74和0.79微克/毫升.
结论:
- 弗莱明吉亚线状植物是生物活性二甲和黄的来源.
- 弗莱米利纳丁C (2) 和弗拉万5显示出作为抗疟疾药物的显著潜力.
- 对这些化合物的进一步研究可能会导致开发新的抗疟疾药物.
相关概念视频
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


